menu search

Trinity biotech stock surges after $45m capital infusion from korea-based firm

Trinity Biotech plc (NASDAQ: TRIB) announced a $45 million investment and partnership with MiCo Ltd, a KOSDAQ-listed and Korea-based company. MiCo...

April 11, 2022, 11:54 am

Integer adds proprietary biomaterial technologies via €120m acquisition

Integer Holdings Corporation (NYSE: ITGR) acquired Connemara biomedical Holdings Teoranta and its su...

April 7, 2022, 1:01 pm

Pharmadrug advances dmt-analogue glaucoma program with fabrication of medical device to lower intraocular pressure

PharmaDrug Inc announced that, in collaboration with the Terasaki Institute for biomedical Innovation ...

April 7, 2022, 9:27 am

Medx signs distribution agreement with vitamed biomedical to launch its teledermatology screening platform in italy

MedX Health Corp. (TSX-V:MDX) said it has signed a commercial distribution agreement with Vitamed biomedical ...

April 4, 2022, 9:57 am

T2 biosystems secures additional barda funding to develop blood test panels to detect sepsis-causing pathogens

The biomedical Advanced Research and Development Authority (BARDA) is providing an additional $4.4 mil...

April 1, 2022, 11:05 am

Talis biomedical corporation (tlis) ceo rob kelly on q4 2021 results - earnings call transcript

Talis biomedical Corporation (TLIS) CEO Rob Kelly on Q4 2021 Results - Earnings Call Transcript...

March 15, 2022, 10:09 pm

Clearside biomedical, inc. (clsd) ceo george lasezkay on q4 2021 results - earnings call transcript

Clearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q4 2021 Results - Earnings Call Transcript...

March 10, 2022, 9:17 pm

Clearside biomedical, inc. (clsd) q4 earnings and revenues beat estimates

Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of 244.44% and 95.19%, respectively, for the quarter ended December 2021. D...

March 10, 2022, 6:48 pm

Pharmadrug announces positive results from dmt-analogue program to treat glaucoma

PharmaDrug Inc announced that it has successfully completed a head-to-head potency comparator study of its two undisclosed DMT-analogue candidates for...

February 23, 2022, 9:10 am

Pharmadrug announces positive results from dmt-analogue program to treat glaucoma

PharmaDrug Inc announced that it has successfully completed a head-to-head potency comparator study of its two undisclosed DMT-analogue candidates for...

February 23, 2022, 9:10 am

Pharmadrug announces positive results from dmt-analogue program to treat glaucoma

PharmaDrug Inc announced that it has successfully completed a head-to-head potency comparator study of its two undisclosed DMT-analogue candidates for...

February 23, 2022, 9:10 am

Petvivo holdings, inc. to announce results for third quarter ended december 31, 2021 [updated]

MINNEAPOLIS, MN, US, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging ...

February 3, 2022, 6:05 pm

Petvivo holdings, inc. to announce results for third quarter ended december 31, 2021 [updated]

MINNEAPOLIS, MN, US, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging ...

February 3, 2022, 6:05 pm

Petvivo holdings, inc. to announce results for third quarter ended december 31, 2021 [updated]

MINNEAPOLIS, MN, US, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging ...

February 3, 2022, 6:05 pm

Psychedelics biotech startup launches phase 1 study on ayahuasca's active ingredient

Psychedelics biotech startup Entheon biomedical ENBI ENTBF announced the approval by the local Dutch et...

February 3, 2022, 1:53 pm

Psychedelics biotech startup launches phase 1 study on ayahuasca's active ingredient

Psychedelics biotech startup Entheon biomedical ENBI ENTBF announced the approval by the local Dutch et...

February 3, 2022, 1:53 pm

Psychedelics biotech startup launches phase 1 study on ayahuasca's active ingredient

Psychedelics biotech startup Entheon biomedical ENBI ENTBF announced the approval by the local Dutch et...

February 3, 2022, 1:53 pm

4 top biotech stocks to gain amid industry challenges

New drug approvals and development of treatments for COVID-19 should maintain momentum for the Zacks biomedica...

February 1, 2022, 9:59 am

4 top biotech stocks to gain amid industry challenges

New drug approvals and development of treatments for COVID-19 should maintain momentum for the Zacks biomedica...

February 1, 2022, 9:59 am

4 top biotech stocks to gain amid industry challenges

New drug approvals and development of treatments for COVID-19 should maintain momentum for the Zacks biomedica...

February 1, 2022, 9:59 am


Search within

Pages Search Results: